PRGO

Perrigo acquires Laboratorios Diba - 10/07 - 09:21 AM ET

PRGO: To Present At JMP Securities Healthcare Conference @ 09:30 ET [delayed] - 10/06 - 08:54 AM ET

Perrigo Acquires Mexican Manufacturer Laboratorios Diba, S.A. - 10/06 - 07:49 AM ET

PRGO touches 200-day moving average at 34.96 - 10/06 - 11:03 AM ET

Perrigo Company to Present at the JMP Securities 2008 Healthcare Focus Conference - 10/03 - 08:14 AM ET

Perrigo buys US co JB Laboratories: Parrigo will pay $44 million in cash for the company. - 09/17 - 03:40 PM ET

CREDIT SUISSE RAISES PERRIGO CO TO OUTPERFORM FROM NEUTRAL - THEFLYONTHEWALL.COM - 09/17 - 06:59 AM ET

Perrigo Company announces purchase of JB Laboratories - 09/17 - 04:32 AM ET

Perrigo Buys JB Laboratories - 09/16 - 06:16 PM ET

PRGO: To Present At Merrill Lynch Pharmaceutical Conference @ 09:30 ET [delayed] - 09/16 - 07:54 AM ET

PERRIGO CO SAYS DEAL IS EXPECTED TO ADD MORE THAN $70 MLN OF ANNUAL SALES - 09/16 - 07:39 AM ET

PERRIGO CO SAYS ACQUIRED JB LABORATORIES FOR APPROXIMATELY $44 MILLION IN CASH - 09/16 - 07:37 AM ET

Perrigo Acquires JB Laboratories - 09/16 - 07:33 AM ET

Perrigo Company To Present at the Merrill Lynch Global Pharmaceutical Conference - 09/15 - 02:04 PM ET

Above all, they were friends: A Washington state man makes a cross-country trip to visit the Hamburg grave site of a former Air Force buddy killed in action in Vietnam. - 09/12 - 12:31 PM ET

PRGO touches 200-day moving average at 34.27 - 09/11 - 10:48 AM ET

PRGO touches 200-day moving average at 35.49 - 09/10 - 02:08 AM ET

Perrigo acquires rights to sell Synthon's allergy drug - 09/09 - 10:50 AM ET

Perrigo Company acquires exclusive sales and distribution rights to Levocetirizine from Synthon - 09/09 - 04:17 AM ET

BRIEF: Perrigo buys US rights to generic Xyzal: Branded Xyzal, an allergy treatment, has $200 million in annual US sales. - 09/08 - 03:42 PM ET

Page 1 of 11     1  2   3   4   5   >   >>|     Previous  |  Next

<< Back to Stock Index